Inducible, Tunable, and Multiplex Human Gene Regulation Using CRISPR-Cpf1
AssigneeThe General Hospital Corporation
InventorsYu Gyoung Tak, Benjamin Kleinstiver, J. Keith Joung
Life of this patent
Estimating the term…
Abstract
Drug-inducible, tunable, and multiplexable Clustered Regularly Interspaced Short Palindromic Repeats from Prevotella and Francisella 1 (Cpf1)-based activators, and methods of use thereof.
Claims18
A fusion protein comprising a catalytically inactive Lachnospiraceae bacterium ND2006 protein Cpf1 (dLbCpf1) fused to at least one activation domain.
A fusion protein comprising a catalytically inactive Lachnospiraceae bacterium ND2006 Cpf1 (dLbCpf1) fused to a conditional dimerization domain, with an optional intervening linker.
A method of increasing expression of a target gene in a cell, the method comprising contacting the cell with, or expressing in the cell, one or more of:
- (i) a fusion protein comprising a catalytically inactive Lachnospiraceae bacterium ND2006 protein Cpf1 (dLbCpf1) fused to at least one activation domain, and at least one crRNA that directs the fusion protein to a regulatory region of the target gene;
- or
- (ii) a first fusion protein comprising a catalytically inactive Lachnospiraceae bacterium ND2006 Cpf1 (dLbCpf1) fused to a conditional dimerization domain, with an optional intervening linker, and a second fusion protein comprising an activation domain fused to a second conditional dimerization domain that dimerizes with the conditional dimerization domain in the first fusion protein in the presence of a dimerizing agent, with an optional intervening linker between the activation domain and the second dimerizing domain, and at least one crRNA that directs the fusion protein to a regulatory region of the target gene.
Dependencies are inferred from the claim text.